Advocacy at a Glance 5/2/21 Advocacy at a Glance 5/2/21 Key Take-Aways from Hill Day (Part One) Read More Analysis and Commentary 1/17/20 Analysis and Commentary 1/17/20 Hill Day and Other Upcoming Alliance Advocacy Initiatives Read More Advocacy at a Glance 2/1/19 Advocacy at a Glance 2/1/19 February 15 Is the New Deadline; Negotiations Begin Read More Advocacy at a Glance 11/11/16 Advocacy at a Glance 11/11/16 Mr. Trump, the Election and FDA Read More Advocacy at a Glance 11/7/16 Advocacy at a Glance 11/7/16 FDA and the Elections: Many Unknowns Read More Advocacy at a Glance 10/1/16 Advocacy at a Glance 10/1/16 CR through December 9 Passes; Congress in Recess Read More Advocacy at a Glance 9/23/16 Advocacy at a Glance 9/23/16 Continuing Resolution Still in Negotiations; One Week to Go or Else Read More
Advocacy at a Glance 5/2/21 Advocacy at a Glance 5/2/21 Key Take-Aways from Hill Day (Part One) Read More
Analysis and Commentary 1/17/20 Analysis and Commentary 1/17/20 Hill Day and Other Upcoming Alliance Advocacy Initiatives Read More
Advocacy at a Glance 2/1/19 Advocacy at a Glance 2/1/19 February 15 Is the New Deadline; Negotiations Begin Read More
Advocacy at a Glance 11/11/16 Advocacy at a Glance 11/11/16 Mr. Trump, the Election and FDA Read More
Advocacy at a Glance 11/7/16 Advocacy at a Glance 11/7/16 FDA and the Elections: Many Unknowns Read More
Advocacy at a Glance 10/1/16 Advocacy at a Glance 10/1/16 CR through December 9 Passes; Congress in Recess Read More
Advocacy at a Glance 9/23/16 Advocacy at a Glance 9/23/16 Continuing Resolution Still in Negotiations; One Week to Go or Else Read More
